| Catalog Number |
51956 / 93-4450 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Erosion (1750); Fistula (1862); Foreign Body Reaction (1868); Micturition Urgency (1871); Hemorrhage/Blood Loss/Bleeding (1888); Unspecified Infection (1930); Inflammation (1932); Neuropathy (1983); Pain (1994); Scar Tissue (2060); Urinary Retention (2119); Urinary Tract Infection (2120); Abnormal Vaginal Discharge (2123); Urinary Frequency / Polyuria (2275); Deformity/ Disfigurement (2360); Abdominal Cramps (2543); Neuralgia (4413); Dyspareunia (4505); Urinary Incontinence (4572); Pelvic Pain (4865)
|
| Date of Event |
01/10/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The lot number was reviewed for complaint trend, nonconforming report and capa.Devices met specification prior to release.No trends were noted for complaints and there were no nonconforming reports or capas that were confirmed in veeva to be associated.
|
| |
|
Event or Problem Description
|
|
As reported to coloplast, though not verified: following a supris being implanted in the patient, the patient had recurrent stress urinary incontinence, mesh erosion requiring trimming under local anesthesia and a history or urethral fistula repair.
|
| |
|
Event or Problem Description
|
|
As additionally reported to coloplast, though not verified, the patient with this device also experienced urinary tract infection, bulkamid periurethral injections, excision of urethrovaginal fistula, urethroplasty, bilateral ureteral catheterization and cystoscopy under laryngeal mask anesthesia.Findings included residual mid urethral sling mesh found deeper in the sulcus which was noted to have no relation to the urethrovaginal fistula tract.Pathology report noted squamous mucosa with chronic inflammation and foreign body giant cells surrounding polarizable material.The patient was scheduled for revision surgery.
|
| |
|
Additional Manufacturer Narrative
|
|
This complaint was investigated to the extent information was provided to coloplast.Due to the legal nature of this complaint and the device not being returned for evaluation a thorough investigation could not be executed.Complaints of this nature are monitored and captured within the product risk documentation.No further action or corrective action is required at this time.Correction: h6 health effect clinical code e2314 fistula was removed.
|
| |
|
Event or Problem Description
|
|
As additionally reported to coloplast, though not verified: following implant of the supris, the patient subsequently suffered complications associated with the pelvic mesh product, including, exposure of the mesh, protrusion of the mesh, mesh contraction, scarring, bleeding, extreme pelvic and abdominal pain and cramping, irregular discharge, vaginal pain, dyspareunia, urinary urgency problems, permanent disfigurement, infection, trouble voiding, nerve damage and pain and difficulty with daily activities, which required surgical revision and/or removal procedures.The patient has reportedly also had to use pain control and other medications and operations to remove portions of the female genitalia.
|
| |
|
Event or Problem Description
|
|
As additionally reported to coloplast, though not verified: the patient underwent further urethrolysis in 2024.Cystourethroscopy intraoperative findings included significant peri-urethral scar formation.No vaginal mesh found and no urethrovaginal fistula noted.Patient continued to have some air passage per urethra, urge incontinence, frequency and overactive bladder.
|
| |
|
Search Alerts/Recalls
|